Verizon Communications, Inc.:  Implementing a Human Resources Balanced Scorecard

Srikant M. Datar; Marc J. Epstein; Jeremy  Cott

Case | HBS Case Collection | June 2001 (Revised October 2001)

Verizon Communications, Inc.: Implementing a Human Resources Balanced Scorecard

by Srikant M. Datar, Marc J. Epstein and Jeremy Cott

Abstract

In early 2000, Verizon Communications implemented a Human Resources Balanced Scorecard to evaluate the effectiveness of and payoffs from human resource management. This case describes the benefits of the scorecard and the challenges of measurement and implementation. Teaching Purpose: To help students understand: 1) how to implement a Balanced Scorecard, 2) how to measure and improve the effectiveness of support functions, and 3) how to link nonfinancial measures to financial measures of support functions when financial benefits are difficult to quantify.

Keywords: Balanced Scorecard; Human Resources; Telecommunications Industry;

Language: English

Format: Print

23 pages

Educators Purchase

Citation:

Datar, Srikant M., Marc J. Epstein, and Jeremy Cott. "Verizon Communications, Inc.: Implementing a Human Resources Balanced Scorecard." Harvard Business School Case 101-102, June 2001. (Revised October 2001.)

Set in December 2019, this case explores how P&G has applied data science and analytics to cut costs and improve outcomes across its business units. The case provides an overview of P&G’s approach to data management and governance, and reviews the challenges associated with changing long-established work processes within the company. It concludes by exploring four examples of how P&G has applied analytics to its businesses.

Prozac is widely hailed as “a breakthrough drug for depression.” In 2020, the World Health Organization (WHO) estimated that over 264 million people worldwide suffer from depression, and 800,000 die by suicide each year. In 2014, researchers calculated the economic impact of depression—in terms of lost productivity, absenteeism, and treatment costs—to be USD$63 billion per year in the United States alone. Depression’s toll on lives and livelihoods prompted the WHO to place Prozac on its list of essential medicines in 2009.

Tamoxifen is considered a “gold standard” treatment for millions of breast cancer patients. In 1985, twelve years after Imperial Chemical Industries (ICI), had first introduced tamoxifen in the United Kingdom (UK), the World Health Organization (WHO) designated it an essential cancer drug. In 2003, V. Craig Jordan, a leading tamoxifen researcher, estimated that “over 400,000 women are alive…as a result of tamoxifen therapy.”

Faculty & Research

Verizon Communications, Inc.: Implementing a Human Resources Balanced Scorecard

Abstract

Citation:

About the Author

More from the Author